Lipoprotein Lipase, Amylase and Triglyceride Alteration: Lean Diabetic and Obese (Non-Diabetic) Patients

Authors

  • Kamal Eldin Ahmed Abdelsalam College of Applied Medical Sciences - Shaqraa University - KSA Associate Professor: Chemical Pathology

Keywords:

Lipase, amylase, triglyceride, obese, diabetes mellitus

Abstract

Obesity, as well as type 2 diabetes mellitus, is a significant issue for health policy because it is so widespread in the population as a whole, and because of the high risk of complications it carries. Serum lipase and pancreatic amylase concentrations are used in conjunction with clinical findings to diagnose pancreatic disorders. The aim of this study was to differentiate the alterations in fasting dyslipidemia and serum levels of pancreatic enzymes in lean diabetics and non-diabetic obese. Triglyceride, lipase and amylase were measured in the serum collected from overnight fasting 300 volunteers those were separated into 3 groups; control group (non-diabetic and with normal weight), diabetics (normal weight) group and obese (non-diabetic) group. In this study, serum levels of triglyceride, amylase and lipase were significantly changed in obese group when compared to control group. But, only of triglyceride and amylase were increased significantly in diabetic group when compared to control group. On the other hand, serum lipase showed significant increase diabetic group when compared to obese group. In conclusion, serum triglyceride and amylase concentrations were higher in obese subjects than those with normal weight. The results of this study illustrated that serum lipase concentrations were decreased in obese subjects but increased in diabetic patients compared to the normal healthy subjects.

Author Biography

Kamal Eldin Ahmed Abdelsalam, College of Applied Medical Sciences - Shaqraa University - KSA Associate Professor: Chemical Pathology

Associate Professor: Chemical Pathology

Department of Clinical Laboratory Sciences

References

M. I. Yasawy, A. A. Al-Quorain, A. M. Hussameddin, Z. M. Yasawy, and R. M. Al-Sulaiman, "Obesity and gastric balloon," J Family Community Med, vol. 21, pp. 196-9, Sep 2014.

D. Haslam, "Obesity: a medical history," Obesity Reviews, vol. 8, pp. 31-36, 2007.

A. Abdullah, A. Peeters, M. de Courten, and J. Stoelwinder, "The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies," Diabetes Res Clin Pract, vol. 89, pp. 309-19, Sep 2010.

V. Rebours, S. Gaujoux, G. D, A. Sauvanet, P. Ruszniewski, P. Levy, and his colleagues ., "1044 Obesity Is a Risk Factor for Pancreatic Precancerous Lesions," Gastrointestinal Endoscopy, vol. 79, p. AB191.

A. L. Schneider, M. Lazo, C. E. Ndumele, J. S. Pankow, J. Coresh, J. M. Clark, and his colleagues ., "Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study," Diabet Med, vol. 30, pp. 926-33, Aug 2013.

S. Oppliger, S. Hartnack, B. Riond, C. E. Reusch, and P. H. Kook, "Agreement of the serum Spec fPL and 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester lipase assay for the determination of serum lipase in cats with suspicion of pancreatitis," J Vet Intern Med, vol. 27, pp. 1077-82, Sep-Oct 2013.

A. Mahajan, R. Kadavigere, S. Sripathi, G. S. Rodrigues, V. R. Rao, and P. Koteshwar, "Utility of serum pancreatic enzyme levels in diagnosing blunt trauma to the pancreas: A prospective study with systematic review," Injury, vol. 45, pp. 1384-93, Sep 2014.

M. F. Philippe, S. Benabadji, L. Barbot-Trystram, D. Vadrot, C. Boitard, and E. Larger, "Pancreatic volume and endocrine and exocrine functions in patients with diabetes," Pancreas, vol. 40, pp. 359-63, Apr 2011.

S. M. Grundy, H. B. Brewer, Jr., J. I. Cleeman, S. C. Smith, Jr., and C. Lenfant, "Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition," Arterioscler Thromb Vasc Biol, vol. 24, pp. e13-8, Feb 2004.

M. Nassar, N. Hiraishi, M. S. Islam, M. Otsuki, and J. Tagami, "Age-related changes in salivary biomarkers," Journal of Dental Sciences, vol. 9, pp. 85-90.

L. Yang, S. J. Chen, G. Y. Yuan, L. B. Zhou, D. Wang, X. Z. Wang, and his colleagues ., "Association of serum adipose triglyceride lipase levels with obesity and diabetes," Genet Mol Res, vol. 13, pp. 6746-51, 2014.

N. J. MacKay, "Scaling of human body mass with height: the body mass index revisited," J Biomech, vol. 43, pp. 764-6, Mar 3 2010.

J. Malloy, K. Gurney, K. Shan, P. Yan, and S. Chen, "Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes," Diabetes Metab Syndr Obes, vol. 5, pp. 419-24, 2012.

A. Tirosh, I. Shai, R. Bitzur, I. Kochba, D. Tekes-Manova, E. Israeli, and his colleagues ., "Changes in triglyceride levels over time and risk of type 2 diabetes in young men," Diabetes Care, vol. 31, pp. 2032-7, Oct 2008.

N. Freemantle, J. Holmes, A. Hockey, and S. Kumar, "How strong is the association between abdominal obesity and the incidence of type 2 diabetes?," Int J Clin Pract, vol. 62, pp. 1391-6, Sep 2008.

V. Van Harmelen, S. Reynisdottir, P. Eriksson, A. Thorne, J. Hoffstedt, F. Lonnqvist, and his colleagues ., "Leptin secretion from subcutaneous and visceral adipose tissue in women," Diabetes, vol. 47, pp. 913-7, Jun 1998.

M. A. Sayeed, A. K. Azad Khan, H. Mahtab, K. A. Ahsan, A. Banu, P. A. Khanam, and his colleagues ., "Leptin is reduced in lean subjects with type 2 diabetes in bangladesh," Diabetes Care, vol. 26, p. 547, Feb 2003.

R. S. Ahima, "Revisiting leptin's role in obesity and weight loss," J Clin Invest, vol. 118, pp. 2380-3, Jul 2008.

R. Coppari and C. Bjorbaek, "Leptin revisited: its mechanism of action and potential for treating diabetes," Nat Rev Drug Discov, vol. 11, pp. 692-708, Sep 2012.

M. Naito, J. Fujikura, K. Ebihara, F. Miyanaga, H. Yokoi, T. Kusakabe, and his colleagues ., "Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice," Diabetes, vol. 60, pp. 2265-73, Sep 2011.

F. Picard, D. Richard, Q. Huang, and Y. Deshaies, "Effects of leptin adipose tissue lipoprotein lipase in the obese ob/ob mouse," Int J Obes Relat Metab Disord, vol. 22, pp. 1088-95, Nov 1998.

K. Gajda, A. Sulich, J. Hamulka, and A. Bialkowska, "Comparing diabetic with non-diabetic overweight subjects through assessing dietary intakes and key parameters of blood biochemistry and haematology," Rocz Panstw Zakl Hig, vol. 65, pp. 133-8, 2014.

T. Bojadzievski and R. A. Gabbay, "Patient-centered medical home and diabetes," Diabetes Care, vol. 34, pp. 1047-53, Apr 2011.

Downloads

Published

2015-07-01

How to Cite

Abdelsalam, K. E. A. (2015). Lipoprotein Lipase, Amylase and Triglyceride Alteration: Lean Diabetic and Obese (Non-Diabetic) Patients. International Journal of Sciences: Basic and Applied Research (IJSBAR), 23(2), 95–103. Retrieved from https://gssrr.org/index.php/JournalOfBasicAndApplied/article/view/4291

Issue

Section

Articles